ghk-cu clinical trials safety Peptide: Benefits, Safety, Dosage, Research Frontiers | Exploring the beneficial

These include [6, 34, 39]: Irritation at the site of injection Fatigue Nausea Light-headedness Sweatin g Adverse effects are often attributable to low-grade peptides

Disclaimer: Compounded preparations are customized for individual patients and have not been evaluated or approved by the FDA for safety or efficacy

Once reconstituted, keep at 28C and use within 30 days for maximum stability

GHK-Cu continues to be studied for its potential to improve tissue healing and skin quality

The tripeptide modulates over 4,000 human genes (31.2% of the genome) and plasma levels decline from approximately 200 ng/mL at age 20 to less than half by age 60 (Pickart & Margolina, 2018)